The DNA damage response network in the treatment of head and neck squamous cell carcinoma

BACKGROUND: We sought to determine whether DNA damage response (DDR)-related aberrations predict therapeutic benefit in cisplatin-treated head and neck squamous cell carcinoma (HNSCC) patients and how DDR pathways are modulated after treatment with olaparib alone or in combination with cisplatin or...

Descripción completa

Detalles Bibliográficos
Autores principales: Psyrri, A., Gkotzamanidou, M., Papaxoinis, G., Krikoni, L., Economopoulou, P., Kotsantis, I., Anastasiou, M., Souliotis, V.L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957155/
https://www.ncbi.nlm.nih.gov/pubmed/33714009
http://dx.doi.org/10.1016/j.esmoop.2021.100075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957155/
https://www.ncbi.nlm.nih.gov/pubmed/33714009
http://dx.doi.org/10.1016/j.esmoop.2021.100075

Ejemplares similares